20-Year Public Health Predictions for Chronic Hepatitis C-Related Morbidity and Mortality–A GEHMO Simulation
U Siebert, G Sroczynski, A Conrads-Frank, JB Wong, S Rossol · Zeitschrift für Gastroenterologie · 2004 · Heft 08
Bibliografische Angaben
Zusammenfassung
Objective: To assess the public health impact of different antiviral therapies (AVT) for chronic hepatitis C (CHC) when accounting for CHC-related diseases (e.g., HIV/HCV co-infection, haemophilia, history of i.v. drug use). Methods: Design: We used a Markov model, the German Hepatitis C Model (GEHMO) [1], combined with with prevalence and incidence cohort simulation. Data Sources: Pooled efficacy data from clinical trials and literature-based epidemiologic data on CHC and co-morbidities. Target Population: All treatable treatment-naïve German patients with known CHC and elevated ALT levels. Time Horizon: 20 yea…